Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genesco (GCO) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Genesco (GCO) over the last 16 years, with Q4 2025 value amounting to $3.9 million.

  • Genesco's Asset Writedowns and Impairment rose 278208.96% to $3.9 million in Q4 2025 from the same period last year, while for Nov 2025 it was $4.8 million, marking a year-over-year increase of 44948.34%. This contributed to the annual value of $1.4 million for FY2025, which is 4446.76% up from last year.
  • Latest data reveals that Genesco reported Asset Writedowns and Impairment of $3.9 million as of Q4 2025, which was up 278208.96% from $34000.0 recorded in Q2 2025.
  • In the past 5 years, Genesco's Asset Writedowns and Impairment ranged from a high of $3.9 million in Q4 2025 and a low of $34000.0 during Q2 2025
  • Its 5-year average for Asset Writedowns and Impairment is $614812.5, with a median of $276000.0 in 2023.
  • In the last 5 years, Genesco's Asset Writedowns and Impairment tumbled by 9951.02% in 2021 and then skyrocketed by 278208.96% in 2025.
  • Over the past 5 years, Genesco's Asset Writedowns and Impairment (Quarter) stood at $225000.0 in 2021, then plummeted by 42.67% to $129000.0 in 2022, then decreased by 23.26% to $99000.0 in 2023, then soared by 35.35% to $134000.0 in 2024, then surged by 2782.09% to $3.9 million in 2025.
  • Its Asset Writedowns and Impairment was $3.9 million in Q4 2025, compared to $34000.0 in Q2 2025 and $890000.0 in Q1 2025.